Cover Image

Corrigendum to “Lecanemab for treatment of individuals with early Alzheimer’s Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes” (The Journal of Prevention of Alzheimer's Disease (2026) 100507): corrigendum

Show other versions (1)
Saved in:
Bibliographic Details
Main Authors: Perry, Richard (Author) , Kipps, Christopher (Author) , Martín, Maria Eugenia Soto (Author) , Bozzali, Marco (Author) , Logroscino, Giancarlo (Author) , Trafford, Sarah (Author) , Dhadda, Shobha (Author) , Kanekiyo, Michio (Author) , Goodwin, Amanda (Author) , Hodgkinson, Mark (Author) , Hersch, Steven (Author) , Irizarry, Michael (Author) , Kramer, Lynn (Author) , Frölich, Lutz (Author)
Format: Article (Journal) Editorial
Language:English
Published: April 2026
In: The journal of prevention of Alzheimer's disease
Year: 2026, Volume: 13, Issue: 4
ISSN:2426-0266
DOI:10.1016/j.tjpad.2026.100527
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.tjpad.2026.100527
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2274580726000518
Get full text
Author Notes:Richard Perry, Christopher Kipps, Maria Eugenia Soto Martín, Marco Bozzali, Giancarlo Logroscino, Sarah Trafford, Shobha Dhadda, Michio Kanekiyo, Amanda Goodwin, Mark Hodgkinson, Steven Hersch, Michael Irizarry, Lynn Kramer, Lutz Froelich
Description
Item Description:Online verfügbar: 14. März 2026, Artikelversion: 14. März 2026
Gesehen am 16.04.2026
Physical Description:Online Resource
ISSN:2426-0266
DOI:10.1016/j.tjpad.2026.100527

Similar Items